Last reviewed · How we verify

Non-Vitamin K Oral Antagonists

Abbott Medical Devices · Phase 1 active Small molecule

Non-Vitamin K Oral Antagonists is a Small molecule drug developed by Abbott Medical Devices. It is currently in Phase 1 development. Also known as: NOAC.

At a glance

Generic nameNon-Vitamin K Oral Antagonists
Also known asNOAC
SponsorAbbott Medical Devices
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Non-Vitamin K Oral Antagonists

What is Non-Vitamin K Oral Antagonists?

Non-Vitamin K Oral Antagonists is a Small molecule drug developed by Abbott Medical Devices.

Who makes Non-Vitamin K Oral Antagonists?

Non-Vitamin K Oral Antagonists is developed by Abbott Medical Devices (see full Abbott Medical Devices pipeline at /company/abbott-medical-devices).

Is Non-Vitamin K Oral Antagonists also known as anything else?

Non-Vitamin K Oral Antagonists is also known as NOAC.

What development phase is Non-Vitamin K Oral Antagonists in?

Non-Vitamin K Oral Antagonists is in Phase 1.

Related